Reading the tape
NASDAQ: COLL
Collegium Pharmaceutical, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
Market Cap
$1.12B
52w High
$50.79
52w Low
$26.72
P/E
17.44
Volume
361.66K
Outstanding Shares
32.41M
Price vs Fundamentals
Why The Stock Is Moving
Fundamentals are supporting the moveModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 24.48%Revenue (TTM): 23.62%FCF (TTM): 61.11%P/FCF: 13th pct
What changed
The stock rose 24.48% over the last year. Revenue grew 23.62% over the trailing twelve months. Operating margin moved from 26.91% to 23.01%. Free cash flow grew 61.11% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 13th percentile of their historical P/FCF range.
What would invalidate this read
Operating margin is at 23.01%. Revenue grew 23.62% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Company profile
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management.
CEOVikram Karnani
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees357
IPO dateMay 7, 2015
Valuation
Forward P/E—
EV/EBITDA5.38
Enterprise value$2.16B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth12.92%
Gross margin59.35%▼0.69%vs FY2024
Operating margin23.01%▼10.92%vs FY2024
ROE20.84%▼31.07%vs FY2024
Analyst consensus
RatingBuy
Target price$58.00▲67.73%
8
Buy
3
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
Q2 FY26 · EPS est $1.52 · Revenue est $184.47M
View